Header cover image

Finnish Pharmaceuticals & Biotech Spotless Management

Results

1

0 new

Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.

1 companies

Orion Oyj

Market Cap: €6.8b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€48.50

7D

-12.5%

1Y

46.2%